Pagina 1 van 1

Bewijs dat Nederland geld stopte in PACE trial

Geplaatst: 20 feb 2011, 16:23
door zonaanbidster
Comment
www.thelancet.com

Published online February 18, 2011

Chronic fatigue syndrome: where to PACE from here?

*Gijs Bleijenberg, Hans Knoop

Expert Centre for Chronic Fatigue, Ra

dboud University Nijmegen

Medical Centre, 6500 HB Nijmegen, Netherlands G.Bleijenberg@nkcv.umcn.nl

In The Lancet, Peter White and colleagues1 report the four-group PACE randomised trial in adults with chronic fatigue syndrome. PACE stands for “Pacing, graded Activity, and Cognitive behaviour therapy: a randomised Evaluation”. The investigators report the efficacy of three behaviour interventions and specialist medical care. The Article provides a useful panel to summarise the interventions.

PACE tested the safety of the interventions. Concerns about the safety of cognitive behaviour therapy and graded exercise therapy have been raised more than once by patients’ advocacy groups. Few patients receiving cognitive behaviour therapy or graded exercise therapy in the PACE trial had serious adverse reactions and no more than those receiving adaptive pacing therapy or standard medical care, which for cognitive behavioural therapy has already been shown.2 This finding is important and should be communicated to patients to dispel unnecessary concerns about the possible detrimental effects of cognitive behaviour therapy and graded exercise therapy, which will hopefully be a useful reminder of the potential positive effects of both interventions.

Another important aspect of PACE (the largest randomised trial of cognitive behaviour therapy and graded exercise therapy to date) is that the efficacy of both interventions was compared with another therapy and specialist medical care alone. Also, for the first time, adaptive pacing therapy was empirically tested. Both graded exercise therapy and cognitive behaviour therapy assume that recovery from chronic fatigue syndrome is possible and convey this hope more or less explicitly to patients. Adaptive pacing therapy emphasises that chronic fatigue syndrome is a chronic condition, to which the patient has to adapt. Although PACE was not intended to compare cognitive behaviour therapy and graded exercise therapy with each other, there was actually no difference between the two. Both were more effective than adaptive pacing.

Graded exercise therapy and cognitive behaviour therapy might assume that recovery from chronic fatigue syndrome is possible, but have patients recovered after treatment? The answer depends on one’s definition of

recovery.3 PACE used a strict criterion for recovery: a score on both fatigue and physical function within the range of the mean plus (or minus) one standard deviation of a healthy person’s score. In accordance with this criterion, the recovery rate of cognitive behaviour therapy and graded exercise therapy was about 30%—although not very high, the rate is significantly higher than that with both other interventions.

Although the PACE trial shows that recovery from chronic fatigue syndrome is possible, there is clearly room for improvement with both interventions (cognitive behaviour therapy and graded exercise therapy). Both interventions could be improved if more was known about the mechanisms of change. These mechanisms could differ between the interventions, but we think this is unlikely. The rationale behind graded exercise therapy is that increasing the level of physical activity and fitness will cause symptoms to be reduced. The basis of cognitive behaviour therapy is described in PACE as the fear-avoidance theory. There is little empirical support for these proposed mechanisms of change. Mediation analysis of a randomised trial4 which tested the efficacy of graded exercise therapy for chronic fatigue syndrome showed that a decrease in symptom focusing, rather than an increase in fitness, mediated the reduction in fatigue.

Wiborg and colleagues5 have shown that the effect of cognitive behaviour therapy on fatigue in chronic fatigue syndrome is not mediated by a persistent increase in physical activity. We noted that a decrease in focus on fatigue mediated the effect of cognitive behaviour therapy on fatigue and impairments in patients with the

syndrome.6 Similarly, we have shown that higher levels of perceived activity and an increased sense of control over symptoms contribute to the treatment effect.

The central role of cognition in relation to fatigue might explain why graded exercise therapy is effective and adaptive pacing therapy is not. Both treatments aim to increase activity, but the activity-related cognition is probably different in adaptive pacing therapy—“I have to focus on how fatigued I am in order to stop in time, I can’t do more, I have to stop”—from that in graded exercise therapy—“I am able to do more than I thought I could” (ie, less focused). Remarkably in this context, confidence in the treatment at the start is substantially lower with cognitive behaviour therapy than it is with adaptive pacing therapy. Despite lowered confidence in cognitive behaviour therapy, this therapy is more effective than is adaptive pacing therapy. Patient’s confidence in treatment can only change if a change in abilities is perceived, which generally seems to happen in cognitive behaviour therapy.

Future studies into mechanisms of change are urgently needed and could help to improve the efficacy of the interventions, by focusing on the elements that are crucial for change.



*Gijs Bleijenberg, Hans Knoop

Expert Centre for Chronic Fatigue, Ra

dboud University Nijmegen

Medical Centre, 6500 HB Nijmegen, Netherlands G.Bleijenberg@nkcv.umcn.nl



We have received funding from The Netherlands Organisation for Health Research and Development, the Dutch Cancer Society, the Dutch MS Research fund, and the Princess Beatrix Foundation.



1 White PD, Goldsmith KA, Johnson AL, et al, on behalf of the PACE trial management group. Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. Lancet 2011; published online Feb 18. DOI:10.1016/S0140-6736(11)60096-2.



2 Heins M, Knoop H, Stulemeijer M, Prins JB, Van der Meer JWM, Bleijenberg G. Possible detrimental effects of cognitive behaviour therapy for chronic fatigue syndrome. Psychother Psychosom 2010; 79: 249–56.



3 Knoop H, Bleijenberg G, Gielissen MFM, van der Meer JWM, White PD.

Is a full recovery possible after cognitive behavioural therapy for chronic fatigue syndrome? Psychother Psychosom 2007; 76: 171–76.



4 Moss-Morris R, Sharon C, Tobin R, Baldi JC. A randomized controlled graded exercise trial for chronic fatigue syndrome: outcomes and mechanisms of change. J Health Psychol 2005; 10: 245–59.



5 Wiborg JF, Knoop H, Stulemeijer M, Prins JB, Bleijenberg G. How does cognitive behaviour therapy reduce fatigue in patients with chronic fatigue syndrome? The role of physical activity. Psychol Med 2010; 40: 1281–87.



6 Wiborg JF, Knoop H, Prins JB, Bleijenberg G. Does a decrease in avoidance behavior and focusing on fatigue mediate the effect of cognitive behaviour therapy for chronic fatigue syndrome? J Psychosom Res 2011; published online Feb 12.



ifte: 02/19/11

Bewijs dat Nederland geld stopte in PACE trial

Geplaatst: 20 feb 2011, 16:25
door Esther
Schok :shock:

Bewijs dat Nederland geld stopte in PACE trial

Geplaatst: 20 feb 2011, 16:32
door marlène
oh my G..

Bewijs dat Nederland geld stopte in PACE trial

Geplaatst: 20 feb 2011, 16:34
door poppetje
Slaat dit echt op de PACE trials??
Het staat onder het commentaarstuk van Bleijenberg, dus slaat het niet op de nederlandse auteurs en dus op de funding die nijmegen krijgt?

Geplaatst: 20 feb 2011, 16:35
door zonaanbidster
We have received funding from The Netherlands Organisation for Health Research and Development, the Dutch Cancer Society, the Dutch MS Research fund, and the Princess Beatrix Foundation.
Een schone taak voor onze belangenbehartigers om hun collegaeclubs eens te vragen waar ze in G$*#naam mee bezig zijn.
Ik herinner me een ander draadje hier over niet aan kankeronderzoek willen betalen....blijkbaar hebben we nu ook een objectieve reden om er geen geld aan te willen geven.
Los ervan zijn ze bij de MS club vergeten dat ze in hetzelfde verdomhoekje zaten als wij zelf?
Dan nog de overheid.....

Geplaatst: 20 feb 2011, 16:43
door poppetje
Lieve allemaal, stop even met schrikken ik denk echt dat het hier alleen slaat op bleijenberg, je moet vaak onder je artikel zetten door wie je gesponsord wordt of waar je subsidie van krijgt.

Ze bedoelen met "the netherlands organisation for health reserach and development" ZonMW
zie: http://www.zonmw.nl/en/organisation/what-is-zonmw/

Je kunt lezen, we have received funding from the Netherlands, ... Organisation for .....

Maar dat moet je bij elkaar lezen en dus relateren aan de auteurs van het stuk, in dit geval betreft het het commentaar van bleijenberg et al., op de PACE trail. Dus het onderschrift betreft volgens mij alleen deze auteurs. Niet de originele PACE studie. Denk ik.

Geplaatst: 20 feb 2011, 18:26
door zonaanbidster
Poppetje heeft gelijk.
Het is 'slechts' bewijs welke Nederlandse organisaties Nijmegen actief steunen.
ZONmw, Kankerfonds, MS fonds en pr. b fonds. Kleine details en groot bewijs hier voor ieder.
Los van de organisaties die we nu nog niet concreet op papier zien.

Voor De Lancetpublicatie heeft Nederland officieel niet een geldstroomrol gespeeld. Officieel niet....
Tenminste daar is dit geen bewijs voor.

Inofficieel durf ik de rol van Nijmegen niet eens harop te suggereren. Nu toch ns vragen wat die fondsen van Nijmegen terugkregen voor hun geld...

Geplaatst: 20 feb 2011, 19:14
door stier
Zijn er dan andere wetenschappers die ook onderzoek naar ME/CVS willen doen (biomedische oorzaken en behandeling) en aan wie subsidie door bovengenoemde partijen wordt geweigerd?

Geplaatst: 20 feb 2011, 19:22
door franktwisk
Aan Stier.

In Nederland zijn er nauwelijks echte ME/CVS-onderzoekers.
Er was er "halve" onderzoeker, maar die is nu uit de running.

In Nederland, België (Maes en de Meirleir), Engeland, VS zijn nagenoeg alle onderzoeksvoorstellen van biomedische wetenschappers afgewezen.

Geplaatst: 20 feb 2011, 19:33
door felixloena
In Nederland, België (Maes en de Meirleir), Engeland, VS zijn nagenoeg alle onderzoeksvoorstellen van biomedische wetenschappers afgewezen.
Maes schrijft hierover in zijn nieuwste boek

Geplaatst: 20 feb 2011, 19:37
door stier
franktwisk schreef:Aan Stier.
In Nederland zijn er nauwelijks echte ME/CVS-onderzoekers.
Er was er "halve" onderzoeker, maar die is nu uit de running.
En daar zit nou net de kern van het probleem lijkt me. We mogen hopen dat er uit de USA overtuigende resultaten komen, anders zal er weinig veranderen m.b.t. berichtgeving in de media en richtlijnen voor behandeling in Nederland.

Geplaatst: 03 mar 2011, 16:19
door annac
Ik heb niet alles gelezen, ben hier nog maar weinig.

Maar wat ik me zo langzamerhand afvraag is waarom er na al die vele jaren niet specifiek onderzoek word gedaan door Nijmegen hoe het toch komt dat, (volgens hun eigen vals onderzoek dan) niet onderzocht wordt hoe het toch komt dat precies steeds die 30 % maar niet verbetert of geneest?

Dus een onderzoek naar speciaal deze groep van 30 %, alle anderen buiten beschouwing latend. Zo onderscheidt men zich toch? I.p.v. in dezelfde sleur door te hobbelen, zonder de naald uit de groef te halen?

Tja, gemak dient de mens.